Skip to main content
. 2018 Apr 5;218(4):654–658. doi: 10.1093/infdis/jiy190

Table 2.

Results of Univariable and Multivariable Logistic Regression Models and Risk Differences of Factors Associated With Acquisition of Multidrug-Resistant Tuberculosis Within 12 Months of Treatment, Russian Federation (n = 709)

Factor OR (95% CI)
P Adjusted OR (95% CI)
P RD, % (95% CI)
Adjusted RD, % (95% CI)
FAST cohort 0.22 (.11–.48) <.001 0.16 (.07–.39) <.001 −9.13 (−12.82 to −5.45) −9.23 (−12.60 to −5.86)
Weeks in hospital (n = 706) 1.09 (1.06–1.11) <.001 1.09 (1.06–1.12) <.001 0.10 (.06–.15) 0.11 (.06–.16)
Male sex 0.95 (.51–1.78) .90 −0.34 (−5.48–4.80)
Single marital statusa 0.68 (.40–1.16) .15 −3.03 (−7.21–1.15)
Urban residence 1.13 (.64–1.97) .66 1.03 (−3.66–5.73)
Any incarceration history 1.05 (.50–2.21) .88 4.50 (−5.74–6.65)
Any smoking history (n = 705) 1.29 (.67–2.49) .44 1.92 (−2.69–6.53)
Alcohol use disordera 1.46 (.85–2.47) .16 2.97 (−1.21–7.25)
Bilateral and cavitary diseasea 1.47 (.87–2.46) .15 3.16 (−1.22–7.55)
Known prior tuberculosis 3.55 (1.82–6.88) <.001 4.16 (1.91–9.07) <.001 14.98 (4.38–25.59) 13.70 (3.97–23.44)
Known hepatitis diagnosis 1.08 (.53–2.19) .99 0.63 (−5.38–6.64)
Known HIV infection 0.34 (.04–2.55) .29 −5.82 (−12.61–.96)
BMIa 0.92 (.85–1.01) .07 −0.57 (−1.15–.10)
Age in y 0.99 (.97–1.01) .39 −0.06 (−2.10–.08)

Data are for 709 patients, unless otherwise indicated.

Abbreviations: BMI, body mass index; CI, confidence interval; HIV, human immunodeficiency virus; OR, odds ratio; RD, risk difference.

aIncluded in the initial model but not in the final model.

HHS Vulnerability Disclosure